GT Biopharma (GTBP) Institutional Ownership $0.73 -0.07 (-9.25%) As of 10:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for GT Biopharma (NASDAQ:GTBP)CurrentInstitutional OwnershipPercentage8.15%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$278.81KNumber ofInstitutional Sellers(last 12 months)0 Get GTBP Insider Trade Alerts Want to know when executives and insiders are buying or selling GT Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GTBP Institutional Buying and Selling by Quarter GT Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2025 Bank of Montreal Can92,530$331K0.0%+531.6%2.830% 8/8/2024DekaBank Deutsche Girozentrale978,358$2.77M0.0%-10.5%69.044% 6/4/2024DekaBank Deutsche Girozentrale1,093,645$47.45M0.1%N/A77.017% 8/2/2023Bank of Montreal Can596,240$262K0.0%N/A1.596% 1/23/2023Baskin Financial Services Inc.151,354$134K0.0%N/A0.466% 11/7/2022Virtu Financial LLC24,864$44K0.0%N/A0.076% 5/5/2022Russell Investments Group Ltd.11,007$31K0.0%N/A0.033% 5/2/2022Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078% 4/20/2022Sigma Planning Corp21,400$62K0.0%N/A0.067% 2/14/2022Gordian Capital Singapore Pte Ltd35,000$107K0.1%N/A0.114% Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/9/2022Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098% 2/4/2022Crumly & Associates Inc.32,163$85K0.0%N/A0.105% 2/3/2022Brighton Jones LLC11,288$34K0.0%N/A0.037% 1/31/2022Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036% 11/16/2021Two Sigma Advisers LP51,100$344K0.0%+243.0%0.242% 11/16/2021Two Sigma Investments LP162,823$1.10M0.0%N/A0.771% 11/15/2021Marshall Wace LLP16,577$112K0.0%-35.7%0.078% 11/15/2021Franklin Resources Inc.28,500$192K0.0%N/A0.135% 11/12/2021Renaissance Technologies LLC84,700$571K0.0%N/A0.401% 11/12/2021Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008% 11/10/2021Goldman Sachs Group Inc.52,426$353K0.0%N/A0.248% 11/9/2021BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468% 11/8/2021State Board of Administration of Florida Retirement System18,224$123K0.0%N/A0.086% 11/8/2021Russell Investments Group Ltd.9,642$64K0.0%N/A0.046% 11/5/2021Welch Group LLC10,000$67K0.0%N/A0.047% 11/4/2021Deutsche Bank AG11,400$77K0.0%-25.7%0.054% 11/2/2021New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039% 8/25/2021Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/17/2021Metropolitan Life Insurance Co NY8,782$136K0.0%N/A0.042% 8/17/2021MetLife Investment Management LLC11,471$178K0.0%N/A0.054% 8/17/2021Citadel Advisors LLC510,058$7.91M0.0%N/A2.414% 8/16/2021California State Teachers Retirement System32,878$510K0.0%N/A0.156% 8/16/2021Charles Schwab Investment Management Inc.57,993$899K0.0%N/A0.274% 8/16/2021State Street Corp374,704$5.81M0.0%N/A1.773% 8/16/2021Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389% 8/16/2021Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/13/2021Northern Trust Corp225,457$3.50M0.0%+555.6%1.067% 8/13/2021Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641% 8/13/2021Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649% 8/12/2021Legal & General Group Plc2,524$39K0.0%N/A0.012% 8/12/2021JPMorgan Chase & Co.9,155$142K0.0%N/A0.043% 8/12/2021The Manufacturers Life Insurance Company13,758$213K0.0%N/A0.065% 8/11/2021Bank of New York Mellon Corp58,711$910K0.0%N/A0.278% 8/11/2021BlackRock Inc.1,413,391$21.91M0.0%N/A6.690% 8/11/2021Deutsche Bank AG15,349$237K0.0%N/A0.073% 8/10/2021Citigroup Inc.6,134$95K0.0%N/A0.029% 8/6/2021Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009% 8/5/2021Rhumbline Advisers18,634$289K0.0%N/A0.088% 8/2/2021New York State Common Retirement Fund20,400$316K0.0%N/A0.097% 8/2/2021Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014% (Data available from 1/1/2016 forward) GTBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GTBP shares? During the previous two years, the following institutional investors and hedge funds held shares of GT Biopharma shares: DekaBank Deutsche Girozentrale ($2.77M), Bank of Montreal Can ($331K).Learn more on GT Biopharma's institutional investors. What percentage of GT Biopharma's stock is owned by institutional investors? 8.15% of GT Biopharma's stock is owned by institutional investors. Learn more on GTBP's institutional investor holdings. Which institutional investors have been buying GT Biopharma's stock? The following institutional investors have purchased GT Biopharma's stock in the last 24 months: DekaBank Deutsche Girozentrale ($1.09M), and Bank of Montreal Can ($77.88K). How much institutional buying is happening at GT Biopharma? Institutional investors have bought a total of 77,879 shares in the last 24 months. This purchase volume represents approximately $278.81K in transactions. Related Companies Soligenix Major Shareholders TherapeuticsMD Major Shareholders Longeveron Major Shareholders HCW Biologics Major Shareholders Bullfrog AI Major Shareholders IM Cannabis Major Shareholders Marker Therapeutics Major Shareholders Leap Therapeutics Major Shareholders Moleculin Biotech Major Shareholders GeoVax Labs Major Shareholders This page (NASDAQ:GTBP) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTBP Stock Alerts